Moderna Counters GSK’s Legal Challenge in RSV Vaccine Patent Dispute
Moderna Inc. has filed counterclaims against GlaxoSmithKline (GSK) in Delaware federal court amid an ongoing legal battle over a vaccine for respiratory syncytial virus (RSV). The filings accuse GSK of neglecting to develop its own RSV vaccine and instead relying on legal avenues to challenge Moderna. Moderna alleges that GSK has manipulated the United States…